sj-pdf-1-cep-10.1177_03331024241235156 - Supplemental material for Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis

Supplemental material, sj-pdf-1-cep-10.1177_03331024241235156 for Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis by Cristina Tassorelli, Kateryna Onishchenko, Rashmi B. Halker Singh, Molly Duan, Laure Dupont-Benjamin, Matthew Hemstock, Corey Voller, Peter McAllister, Stephanie J. Nahas, Pranav Gandhi and Jessica Ailani in Cephalalgia</p